Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Van Hunsel, Florence
189  Ergebnisse:
Personensuche X
?
1

The Therapeutic Potential of Essential Oils in Managing Inf..:

Dontje, Anouk E. W. K. ; Schuiling-Veninga, Catharina C. M. ; van Hunsel, Florence P. A. M....
Pharmaceuticals.  17 (2024)  5 - p. 571 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Medication errors by caregivers in the homes of children di..:

Sabblah, George Tsey ; van Hunsel, Florence ; Taxis, Katja...
Therapeutic Advances in Drug Safety.  15 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
3

Safety Monitoring of COVID-19 Vaccines in Persons with Prio..:

Ciccimarra, Francesco ; Luxi, Nicoletta ; Bellitto, Chiara...
Vaccines.  12 (2024)  3 - p. 241 , 2024
Link: https://doi.org/10.3390/..
 
?
4

Menstrual disorders following COVID-19 vaccination: a revie..:

Smaardijk, Veerle R. ; Jajou, Rana ; Kant, Agnes.
Frontiers in Drug Safety and Regulation.  4 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
5

The International Working Group on New Developments in Phar..:

Cooper, Dawn ; Platt, Robert W. ; van Hunsel, Florence...
Clinical Therapeutics.  , 2024
Link: https://doi.org/10.1016/..
 
?
6

Validation of a Novel Method to Assess the Clinical Quality..:

van Rijt-Weetink, Yrea R. J. ; Egberts, Toine C. G. ; van Hunsel, Florence P. A. M....
Drug Safety.  47 (2024)  3 - p. 261-270 , 2024
Link: https://doi.org/10.1007/..
 
?
7

What is the Safety of COVID-19 Vaccines in Immunocompromise..:

Bellitto, Chiara ; Luxi, Nicoletta ; Ciccimarra, Francesco...
Drug Safety.  , 2024
Link: https://doi.org/10.1007/..
 
?
8

Frequency and timing of adverse reactions to COVID-19 vacci..:

Raethke, Monika ; van Hunsel, Florence ; Luxi, Nicoletta...
Vaccine.  42 (2024)  9 - p. 2357-2369 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Table1_Menstrual disorders following COVID-19 vaccination: ..:

Veerle R. Smaardijk ; Rana Jajou ; Agnes Kant.
doi:10.3389/fdsfr.2024.1338466.s001.  , 2024
Link: https://doi.org/10.3389/..
 
?
10

Table1_Menstrual disorders following COVID-19 vaccination: ..:

Veerle R. Smaardijk ; Rana Jajou ; Agnes Kant.
doi:10.3389/fdsfr.2024.1338466.s001.  , 2024
Link: https://doi.org/10.3389/..
 
?
11

sj-docx-1-taw-10.1177_20420986231225850 – Supplemental mate..:

George Tsey Sabblah ; Florence van Hunsel ; Katja Taxis...
doi:10.25384/sage.25100230.v1.  , 2024
Link: https://doi.org/10.25384..
 
?
12

Table1_Menstrual disorders following COVID-19 vaccination: ..:

Veerle R. Smaardijk ; Rana Jajou ; Agnes Kant.
doi:10.3389/fdsfr.2024.1338466.s001.  , 2024
Link: https://doi.org/10.3389/..
 
?
13

sj-docx-1-taw-10.1177_20420986231225850 – Supplemental mate..:

George Tsey Sabblah ; Florence van Hunsel ; Katja Taxis...
doi:10.25384/sage.25100230.v1.  , 2024
Link: https://doi.org/10.25384..
 
?
14

Spontaneously reported adverse events following COVID-19 ba..:

van der Boor, Saskia C. ; Schmitz-de Vries, Else T.J. ; Smits, Dennis...
Vaccine.  41 (2023)  29 - p. 4319-4326 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Elements to assess the quality of information of case repor..:

van Rijt-Weetink, Yrea R. J. ; Chamani, Khoezik ; Egberts, Antoine C. G....
Frontiers in Drug Safety and Regulation.  3 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
1-15